Top by categoryEvery category ranked by need: services, software and firms.
Top software by featureThe best tools for one job, across every software category.
Top companies by countryThe leading B2B firms in each country, category by category.
Popular software rankings
Top Inventory Management Software
Top Supplier Management Software
Top Fleet Management Software
Top Cloud Storage Backup Software
Top Master Data Management Software
Top Document Storage Software
Top 3D Modeling Software
Top Compliance Tracking Software
See all popular software rankings
Popular category rankings
Top Software Development Companies
Top Digital Marketing Companies
Top App Development Companies
Top Web Design Agencies
Top Accounting Firms
Top Recruitment Agencies
Top Advertising Companies
Top Design Agencies
See all popular category rankings
Top companies by country
Top companies in the UK
Top companies in the USA
Top companies in India
Top companies in Canada
Top companies in Australia
Top companies in Germany
Top companies in the UAE
Top companies in Pakistan
See all top companies by country
All rankings All categories How we rank

Venture capital firm

Atalanta Therapeutics

Biotechnology company developing RNA interference treatments for neurodegenerative and other brain diseases

Visit Website Get introducedRequest an introduction Write a Review

Own this listing? Claim it

Atalanta Therapeutics cover

About Atalanta Therapeutics

Atalanta Therapeutics is a biotechnology company working on medicines for diseases of the central nervous system. It was created in response to the need for treatments for neurodegenerative conditions.

Its science builds on the founders' work on RNA interference, an approach that aims to stop a disease at its source by silencing the gene behind it.

What Atalanta Therapeutics offers

RNAi therapies: investigational drugs based on branched siRNA.
Huntington's disease work: gene silencing aimed at halting the disease.
Epilepsy research: preclinical data on a therapy for KCNT1-related epilepsy.
Scientific information: explainers on RNA interference and its own approach.

Who it works with

Patients with neurological conditions, served through drug development rather than direct services. Its site carries press releases and leadership news.

Key facts

Focus: central nervous system diseases
Technology: branched siRNA and RNA interference
Stage: investigational and preclinical programmes

Profile written by TrustList from the business's own published information, Sep 2026.

Gallery

2 images - click to enlarge

Categories & features

Rankings

As of 2026-10-10. Organic ranks only; sponsored placements are never ranks.

Ask TrustList to introduce you to Atalanta Therapeutics

Reviews

Write the first review of Atalanta Therapeutics

Used it? Your experience helps other buyers decide.

Questions & answers

No questions yet. Be the first to ask about Atalanta Therapeutics.

Atalanta Therapeutics alternatives

Similar listings buyers compare against this one.

Compare side by side

Operator Collective

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Compare

Zoovu

Product discovery software for B2B and B2C sellers, covering search, guided selling and product content

Compare

AIM Group

Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Compare

500 Global

Global venture capital firm and accelerator backing early-stage technology founders, formerly called 500 Startups

Compare

LAM Capital

Corporate venture investor backing startups in semiconductors, industrial automation and related deep technology

Compare

Vesalius Biocapital Partners

Luxembourg venture capital firm investing in European life science companies across therapeutics, devices and diagnostics

Compare

Keep exploring

More on TrustList

Everything here links back to the same verified catalogue. Pick your next stop.